Literature DB >> 33780375

Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson's Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture.

Keisuke Suzuki1, Ayaka Numao1, Tomoko Komagamine1, Yasuo Haruyama2, Akiko Kawasaki1, Kei Funakoshi1, Hiroaki Fujita1, Shiho Suzuki1, Madoka Okamura1, Tomohiko Shiina1, Koichi Hirata1.   

Abstract

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has negatively affected the mental health of the general population.
OBJECTIVE: We investigated the determinants of quality of life (QOL) in Parkinson's disease (PD) patients during the COVID-19 pandemic.
METHODS: Impacts of lifestyle changes due to the COVID-19 pandemic on 100 patients with PD and their caregivers/spouses were assessed. The Hospital Anxiety and Depression Scale was used to assess anxiety and depression. The physical component summary (PCS) and mental component summary (MCS) scores of the short form (SF)-8 were used to evaluate health-related QOL.
RESULTS: Regarding health-related QOL, physical function, role physical, general health, vitality and the PCS score were significantly worse in PD patients than in caregivers. Worsening of PD-related symptoms, increased stress, and decreased physical activity were observed in 29.0%, 37.0% and 44.0% of PD patients, respectively. Sixteen patients (16.0%) experienced problems with hospital access, but none reported medication shortages. Strong concerns about COVID-19 were reported by 47.0% of caregivers and 50.0% of PD patients. In PD patients, increased gait disturbance and rigidity, disease severity, smoking, the levodopa equivalent dose and decreased body weight predicted a worse PCS score; anxiety, depression, female sex, stress and long disease duration predicted a worse MCS score. In caregivers, age and smoking contributed to a worse PCS score; depression, stress and worsening patient mood contributed to a worse MCS score.
CONCLUSION: We report the negative impacts of the COVID-19 pandemic on health-related QOL and its determinants in PD patients and their caregivers.

Entities:  

Keywords:  COVID-19; Caregivers; Parkinson’s disease; SARS-CoV-2; quality of life

Year:  2021        PMID: 33780375     DOI: 10.3233/JPD-212560

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  18 in total

1.  Spotlight on non-motor symptoms and Covid-19.

Authors:  Silvia Rota; Iro Boura; Yi-Min Wan; Claudia Lazcano-Ocampo; Mayela Rodriguez-Violante; Angelo Antonini; Kallol Ray Chaudhuri
Journal:  Int Rev Neurobiol       Date:  2022-07-09       Impact factor: 4.280

Review 2.  Psychological outcomes of the COVID-19 pandemic in patients with Parkinson's disease: A systematic review.

Authors:  Fardin Nabizadeh; Zahrasadat Seyedalhosseini; Mohammad Balabandian; Mohammad Reza Rostami
Journal:  J Clin Neurosci       Date:  2022-06-28       Impact factor: 2.116

3.  Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care.

Authors:  Katarina Rukavina; Victor McConvey; Kallol Ray Chaudhuri; Janis Miyasaki
Journal:  Int Rev Neurobiol       Date:  2022-04-27       Impact factor: 4.280

4.  Trends in Health Service Use for Canadian Adults With Dementia and Parkinson Disease During the First Wave of the COVID-19 Pandemic.

Authors:  Susan E Bronskill; Laura C Maclagan; Colleen J Maxwell; Andrea Iaboni; R Liisa Jaakkimainen; Connie Marras; Xuesong Wang; Jun Guan; Daniel A Harris; Abby Emdin; Aaron Jones; Nadia Sourial; Claire Godard-Sebillotte; Isabelle Vedel; Peter C Austin; Richard H Swartz
Journal:  JAMA Health Forum       Date:  2022-01-21

5.  The Mental Health of Caregivers and Their Patients With Dementia During the COVID-19 Pandemic: A Systematic Review.

Authors:  Elvira Anna Carbone; Renato de Filippis; Roberta Roberti; Marianna Rania; Laura Destefano; Emilio Russo; Giovambattista De Sarro; Cristina Segura-Garcia; Pasquale De Fazio
Journal:  Front Psychol       Date:  2021-12-24

Review 6.  Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review.

Authors:  S K Brooks; D Weston; N Greenberg
Journal:  Public Health       Date:  2021-09-01       Impact factor: 4.984

7.  Caregiving and Caregiver Health 1 Year into the COVID-19 Pandemic (CUIDAR-SE Study): A Gender Analysis.

Authors:  María Del Río-Lozano; Mar García-Calvente; Belén Elizalde-Sagardia; Gracia Maroto-Navarro
Journal:  Int J Environ Res Public Health       Date:  2022-01-31       Impact factor: 3.390

Review 8.  New Recovery Strategies in Motor and Cognitive Functions, before, during and after Home-Confinement COVID-19, for Healthy Adults and Patients with Neurodegenerative Diseases: Review.

Authors:  Manuela Bacanoiu; Mircea Danoiu; Mihnea Marin; Mihai Robert Rusu; Ligia Rusu
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

9.  A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study.

Authors:  Margherita Fabbri; Clémence Leung; Guillaume Baille; Matthieu Béreau; Christine Brefel Courbon; Giovanni Castelnovo; Nicolas Carriere; Philippe Damier; Luc Defebvre; Anne Doe de Maindreville; Frederique Fluchere; Marie Fuzzatti; David Grabli; David Maltete; Vanessa Rousseau; Agnès Sommet A; Claire Thalamas; Claire Thiriez; Olivier Rascol; Fabienne Ory-Magne
Journal:  Parkinsonism Relat Disord       Date:  2021-07-13       Impact factor: 4.402

10.  Impact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson's Disease in Germany (Care4PD).

Authors:  Odette Fründt; Anne-Marie Hanff; Tobias Mai; Christiane Kirchner; Emma Bouzanne des Mazery; Ali Amouzandeh; Carsten Buhmann; Rejko Krüger; Martin Südmeyer
Journal:  Brain Sci       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.